This inventor holds 2 USPTO granted patents. Top assignee: Danbiosyst UK Limited. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Nicola Christy: Innovator in Lymphatic Delivery Methods
Introduction
Nicola Christy is a prominent inventor based in Nottingham, GB. She has made significant contributions to the field of medical delivery systems, particularly focusing on lymphatic delivery methods. With a total of 2 patents to her name, her work is paving the way for advancements in drug delivery technologies.
Latest Patents
Nicola's latest patents include innovative compositions for delivering active agents to the lymphatic system. One of her notable inventions involves a composition that comprises a plurality of colloidal particles, each associated with an active agent. The surface of these particles is designed to have a hydrophobicity ratio of less than 10. Additionally, a modifying agent can be adsorbed onto the surface, which provides an advancing contact angle of less than 60 degrees. The composition may also meet specific criteria regarding adsorbed layer thickness and albumin uptake ratio. Preferred modifying agents include non-ionic surfactants, particularly block copolymers containing polyethylene glycol.
Career Highlights
Nicola Christy is currently associated with Danbiosyst UK Limited, where she continues to innovate in the field of lymphatic delivery systems. Her work is characterized by a commitment to improving the efficacy of drug delivery methods, which can have a profound impact on patient care.
Collaborations
Nicola collaborates with esteemed colleagues such as Stanley Stewart Davis and Moein Moghimi, contributing to a dynamic research environment that fosters innovation.
Conclusion
Nicola Christy is a trailblazer in the field of lymphatic delivery methods, with her patents reflecting her dedication to advancing medical technology. Her contributions are essential for the future of drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile